A detailed history of Wellington Management Group LLP transactions in Replimune Group, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 242,398 shares of REPL stock, worth $3.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
242,398
Previous 405,516 40.22%
Holding current value
$3.03 Million
Previous $3.65 Million 27.21%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.09 - $11.23 $1.32 Million - $1.83 Million
-163,118 Reduced 40.22%
242,398 $2.66 Million
Q2 2024

Aug 13, 2024

BUY
$5.01 - $9.46 $479,642 - $905,672
95,737 Added 30.9%
405,516 $3.65 Million
Q1 2024

May 15, 2024

BUY
$6.87 - $9.31 $2.13 Million - $2.88 Million
309,779 New
309,779 $2.53 Million
Q4 2023

Feb 12, 2024

BUY
$6.75 - $16.18 $1.66 Million - $3.99 Million
246,624 New
246,624 $2.08 Million
Q3 2023

Nov 14, 2023

BUY
$15.96 - $22.18 $840,022 - $1.17 Million
52,633 Added 25.23%
261,277 $4.47 Million
Q2 2023

Aug 14, 2023

BUY
$15.65 - $24.1 $993,743 - $1.53 Million
63,498 Added 43.75%
208,644 $4.84 Million
Q1 2023

May 12, 2023

SELL
$17.48 - $29.09 $2.43 Million - $4.05 Million
-139,159 Reduced 48.95%
145,146 $2.56 Million
Q4 2022

Feb 13, 2023

BUY
$17.09 - $27.91 $4.41 Million - $7.2 Million
257,842 Added 974.35%
284,305 $7.73 Million
Q3 2022

Nov 14, 2022

SELL
$15.6 - $21.15 $285,417 - $386,960
-18,296 Reduced 40.88%
26,463 $457,000
Q1 2022

May 16, 2022

SELL
$15.24 - $29.75 $3.06 Million - $5.96 Million
-200,492 Reduced 81.75%
44,759 $760,000
Q4 2021

Feb 11, 2022

SELL
$25.43 - $34.25 $3.07 Million - $4.14 Million
-120,758 Reduced 32.99%
245,251 $6.65 Million
Q3 2021

Nov 15, 2021

SELL
$28.98 - $39.54 $14,287 - $19,493
-493 Reduced 0.13%
366,009 $10.8 Million
Q2 2021

Aug 16, 2021

BUY
$28.5 - $39.37 $10.4 Million - $14.4 Million
366,502 New
366,502 $14.1 Million

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $616M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.